Bioharvest Sciences Inc

Company Profile

Bioharvest Sciences Inc had its IPO on under the ticker symbol CNVCF.

The company operates in the Consumer Defensive sector and Packaged Foods industry. Bioharvest Sciences Inc has a staff strength of 0 employees.

Stock update

Shares of Bioharvest Sciences Inc opened at $0.14 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.12 - $0.14, and closed at $0.14.

This is a +4.51% increase from the previous day's closing price.

A total volume of 76,640 shares were traded at the close of the day’s session.

In the last one week, shares of Bioharvest Sciences Inc have increased by +6.92%.

Bioharvest Sciences Inc's Key Ratios

Bioharvest Sciences Inc has a market cap of $76.42 million, indicating a price to book ratio of 91.9557 and a price to sales ratio of 28.1251.

In the last 12-months Bioharvest Sciences Inc’s revenue was $6.96 million with a gross profit of $670000 and an EBITDA of $-10167000. The EBITDA ratio measures Bioharvest Sciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bioharvest Sciences Inc’s operating margin was -151.02% while its return on assets stood at -79.63% with a return of equity of -6364.38%.

In Q0.33333333333333, Bioharvest Sciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 209.4%.

Bioharvest Sciences Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bioharvest Sciences Inc’s profitability.

Bioharvest Sciences Inc stock is trading at a EV to sales ratio of 28.2686 and a EV to EBITDA ratio of -12.6306. Its price to sales ratio in the trailing 12-months stood at 28.1251.

Bioharvest Sciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$8.46 million

Total Liabilities

$9.97 million

Operating Cash Flow

$0

Capital Expenditure

$376000

Dividend Payout Ratio

0%

Bioharvest Sciences Inc ended 2024 with $8.46 million in total assets and $0 in total liabilities. Its intangible assets were valued at $8.46 million while shareholder equity stood at $-5164000.00.

Bioharvest Sciences Inc ended 2024 with $0 in deferred long-term liabilities, $9.97 million in other current liabilities, in common stock, $-71693000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $300000.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Bioharvest Sciences Inc’s total current assets stands at $3.21 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $544000.00 compared to accounts payable of $1.78 million and inventory worth $1.86 million.

In 2024, Bioharvest Sciences Inc's operating cash flow was $0 while its capital expenditure stood at $376000.

Comparatively, Bioharvest Sciences Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.14

52-Week High

$0.323

52-Week Low

$0.129

Analyst Target Price

$

Bioharvest Sciences Inc stock is currently trading at $0.14 per share. It touched a 52-week high of $0.323 and a 52-week low of $0.323. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.14 and 200-day moving average was $0.17 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 3353.1% of the company’s stock are held by insiders while 0% are held by institutions.